Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02679131
Title To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Spectrum Pharmaceuticals, Inc
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Belinostat

Age Groups: adult
Covered Countries USA


No variant requirements are available.